Real-world experience with isatuximab in the treatment of relapsed-refractory multiple myeloma: a case series from the Grand Duchy of Luxembourg.
Hematology (Amsterdam, Netherlands)（2023）
摘要
the clinical cases described illustrate the clinical potential of isatuximab-based treatment for RRMM patient in a real-world setting.
更多查看译文
关键词
CD38,Multiple myeloma,case report,daratumumab,isatuximab,renal impairment,sequencing
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要